Effects of resveratrol on tumor immunity: review
International Journal of Development Research
Effects of resveratrol on tumor immunity: review
Received 19th December, 2020 Received in revised form 24th January, 2021 Accepted 14th February, 2021 Published online 15th March, 2021
Copyright © 2021, Elis Cabral Victor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The purpose of this review was to relate functional aspects of the immune system to cancer and verify if the use of resveratrol may present any adjuvant strategy. The immune system protects the human body against aggressive agents and presents a complex and integrative form of action involving different immune cells. In the neoplastic context, conventional treatment by chemotherapy and radiotherapy generates many side effects. In the neoplastic context, defective cells that are not recognized by immune system and the conventional treatment by chemotherapy and radiotherapy generates relevant collateral effects. Resveratrol has been described as an important immunomodulator. Thus, we raise the following question: if resveratrol can be used as a coadjuvant on cancer treatment?
